Efficacy of Netraseka in Blepharospasm w.s.r to Kruchronmeelana
DOI:
https://doi.org/10.47552/ijam.v11i3.1559Keywords:
Blepharospasm, Apraxia of lid opening, Kruchronmeelana, Aksitarpana, NetrasekaAbstract
Blepharospasm is an act of involuntary blinking. In most of the cases, symptoms last for few days then disappear without any intervention. However in few cases, disease becomes chronic with symptoms of persistent blinking and the person will be able to open his eyes only with a great effort which could eventually lead to a functional blindness. Most of the times it is associated with ALO (Apraxia of lid opening). ALO is an inability to initiate voluntary eyelid opening following a period of eyelid closure. Manual lifting of the eyelid often resolves the problem and lid is able to stay open for a while thereafter. Botulinum toxin injections are the treatment of choice for both Blepharospasm and ALO, which is too expensive and at the same time have only a temporary improvement. In Ayurveda such condition is comparable with Kruchronmeelana which is postulated to be resultant of vata vitiation. Netrakalpana is the therapy of choice to treat above conditions. A single case study done at our department has shown significant improvement both in pain, blinking after the patient was subjected to Netraseka. Before Netraseka the same patient was treated with Aksitarpana which was done with triphala ghrita for seven days, but which hasn't produced much difference neither in pain nor in blinking. Netraseka was given with a specific kashaya for a period of 14 days following Tarpana therapy.
Downloads
Published
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.